Deteksi Dini Karsinoma Sel Basal
Abstract
ABSTRACT
Basal Cell Carcinoma (BCC) is a malignant neoplasm derived from nonkeratinizing cells that originate in the basal layer of the epidermis, which is locally invasive, aggressive, destructive, and rarely metastasize. BCC is more common in the elderly. Etiopathogenesis associated with BCC is genetic, environmental, and most often is exposure to ultraviolet light. Clinically, there are five types of BCC, which are nodular, superficial, morpheaform, pigmented, and fibroepitelioma Pinkus. Early detection of skin cancer can be done with self skin examination. Definitive diagnosis of malignancy is determined by anatomical pathology examination. However, for very early BCC lesion, it’s difficult to determine with hematoxylin eosin staining. Therefore, it is uses Ber-EP4 staining which is specific and highly sensitive for early BCC growing as budding in basal layer of the epidermis and follicles. This finding is particularly significant in the development of molecular pathology and clinical management of BCC lesions or suspected BCC.
ABSTRAK
Karsinoma Sel Basal (KSB) merupakan neoplasma ganas dari sel yang tidak mengalami keratinisasi pada lapisan basal epidermis, bersifat invasif lokal, agresif, destruktif, dan jarang bermetastasis. KSB lebih sering terjadi pada usia lanjut. Etiopatogenesis yang berkaitan dengan KSB adalah genetik, lingkungan, dan yang paling sering adalah paparan sinar ultraviolet. Secara klinis, terdapat lima tipe KSB, yaitu nodular, superfisial, morpheaform, pigmented, dan fibroepitelioma Pinkus. Deteksi dini kanker kulit dapat dilakukan dengan pemeriksaan kulit sendiri (SAKURI). Diagnosis pasti keganasan ditentukan dengan pemeriksaan patologi anatomi. Namun, untuk lesi sangat dini KSB sulit ditentukan dengan pewarnaan hematoksilin eosin. Oleh karena itu, digunakanlah pewarnaan Ber-EP4 yang bersifat spesifik dan sangat sensitif untuk KSB dini yang tumbuh sebagai tunas di lapisan basal epidermis dan folikel. Temuan ini sangat berarti dalam pengembangan patologi molekuler dan penanganan klinis lesi KSB atau yang dicurigai KSB.
Keywords
DOI: 10.33371/ijoc.v10i2.428
Article Metrics
Abstract View: 6773, 
PDF Download: 3751
References
Wasitaatmadja SM. Anatomi kulit. Dalam: Djuanda A, Hamzah M, Aisah S,
penyunting. Buku Ilmu Penyakit Kulit dan Kelamin. Edisi ke-VI. Jakarta: Badan
Penerbit Fakultas Kedokteran Universitas Indonesia. Anonymous. Melanoma Skin
Cancer. American Cancer Society 2005;201:1-52.
Rata IGA. Tumor kulit. Dalam: Djuanda A, Hamzah M, Aisah S, penyunting. Buku
Ilmu Penyakit Kulit dan Kelamin. Edisi ke-6. Jakarta: Badan Penerbit Fakultas
Kedokteran Universitas Indonesia, 2005;229-41.
Carucci JA, Leffel DJ. Basal cell carcinoma. Dalam: Wolff K, Goldsmith LA, Katz SI,
Glicherst BA, Paller AS, Leffel LJ, penyunting. Fitzpatrick’s Dermatology in General
Medicine. 7thed. New York: Mc Graw-Hill; 2008.h. 1036-42.
Rubin AI, Chen EH, Ratner D. Basal cell carcinoma. N Engl J. Med. 2005; 353:2262-9.
Panda, S. Non-melanoma skin cancer in India: current scenario. Indian J Dermatol.
; 55(4): 373-8.
Tjarta A. Spektrum kanker kulit di Indonesia. MDVI 1995;3(22): 100-6.
Bader RS, Santacroce L, Diomede L, Kennedy AS. Basal cell carcinoma. October
[cited 2015, 22nd Feb] Available from URL:http://emedicine.medscape.com
/article/276624-overview
Tiftikcioglu YO, Karaaslan O, Aksoy HM, Aksoy B, Kocer U. Basal cell carcinoma in
Turkey. J Dermatol. 2006; 33(2): 91-5.
Bergman A, Contard P, Spencer J. Multiple basal cell carcinoma in a young adult
treated with Imiquimod 5%: a case report and literature review. January 2005.
[cited 2015, 22nd Feb] Available from URL/ http://jddonline.com/article
/dermatology /S1545961605P0095X/1
Barankin B. Goldenberg G. Nevoid basal cell carcinoma syndrome. January 2015.
[cited 2015, 22nd Feb] Available from URL: http://www.uptodate.com/contents
/nevoid-basal-cellcarcinoma-syndrome
Tilli CM, Steensel MA, Krekels GA, Neumann HA, Ramaekers FC. Molecular
aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol. 2005; 152:
-24.
Cohen PR, Schulze KE, Nelson BR. Basal cell carcinoma with mixed histology: a
possible pathogenesis for recurrent skin cancer. Dermatol Surg. 2006 Apr; 32(4):
-51.
Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare
Dis. 2008 Nov; 3: 32.
Donovan J. Review of the hair follicle origin hypothesis for basal cell carcinoma.
Dermatol Surg. 2009;35(9):1311-23.
Cohen P, Schulze K, Nelson B. Basal cell carcinoma with mixed histology : a possible
pathogenesis for recurrent skin cancer. Dermatol Surg. 2006;32(4):542-51.
Kasper M, et.al. Wounding enhances epidermal tumorigenesis by recruiting hair
follicle keratinocytes. Proc Natl Acad Sci U S A. 2011 Mar; 108(10): 4099–104.
Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and
non-melanoma skin cancer. 2008; 624: 162-78.
Dallaglio KA, Marconi A, Pincelli C. Survivin: a dual player in healthy and diseased
skin. J Invest Dermatol. 2012; 132:18-27.
Mimeault M, Batra SK. Recent advances on skin-resident stem/progenitor cell
functions in skin regeneration, aging and cancers and novel anti-aging and cancer
therapies. 2010. J Cell Mol Med. 2010; 14(1-2): 116-34.
Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003; 327: 794-8.
Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell
carcinoma. Br J Dermatol. 2008;159: 35-48.
Puri T, Gunabushanam G, Sharma R, Kumar S, Julka PK. Extensive bone metastases
from basal cell carcinoma of the eye. Singapore Med. 2006; 47( 9): 811-3.
Handayani I, Kuswadji. Penatalaksanaan karsinoma sel basal. MDVI 1999;
(26):28-34.
American Cancer Society. Atlanta: American Cancer Society, 2015.
Sekretariat Komite Penanggulangan Kanker Nasional (KPKN).Jakarta: KPKN, 2015.
Tan ST. Identifikasi lokasi dan stem cell origin serta faktor yang mempengaruhi lemahnya kemampuan metastasis karsinoma sel basal. Makassar: Fakultas Kedokteran Universitas Hasanuddin; 2012.
Lajhta LG. Stem cell concepts. Differentiation 1979; 14(1-2):23-34.
Refbacks
- There are currently no refbacks.
Email this article 
